Califf Crop

Robert Califf, MD, MACC, will present the Keynote Address at the 2016 Consensus Summit being held October 29, 2016, in Washington, DC, in conjunction with TCT 2016. “We are excited to welcome the new commissioner of the FDA to address this summit, which will focus on creating a consensus document for a translational pathway for future cardiovascular device development that incorporates industry, FDA, and CMS input for cardiovascular disease,” said Nabil Dib, MD, president of the ISCTR.

As the top official of the Food and Drug Administration, Dr. Califf is committed to strengthening programs and policies that enable the agency to carry out its mission to protect and promote the public health. Previously, Dr. Califf served as the FDA’s Deputy Commissioner for Medical Products and Tobacco from February 2015 until his appointment as commissioner in February 2016. In that capacity, he provided executive leadership to the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Tobacco Products. He also oversaw the Office of Special Medical Programs and provided direction for cross-cutting clinical, scientific, and regulatory initiatives, including precision medicine, combination products, orphan drugs, pediatric therapeutics, and the advisory committee system. read more…